Global and neuron but not granulosa cell loss of AR signaling protects against the development of obesity in the PCOS mouse model. (A) Body weight, confirming DHT-induced increased body weight in WT mice and showing no significant increase in body weight in DHT-induced PCOS ARKO or NeurARKO female mice. Data are the mean ± SEM; n = 5 to 9 mice per genotype/treatment group. (B) Parametrial fat deposit weight, showing no significant increase in adiposity in DHT-induced PCOS ARKO or NeurARKO female mice. Data are the mean ± SEM; n = 5 to 9 per genotype/treatment group. (C) Representative dual-energy X-ray absorptiometry images, showing no development of obesity in DHT-induced PCOS ARKO female mice. G, genotype; ns, no significant difference; T, DHT treatment; *, significant difference. (*P < 0.05, two-way ANOVA.)